On a standalone basis, the income from operations rose by 14% to Rs717cr, as compared to Rs628cr of the June quarter of FY21. PAT on a standalone basis was Rs135cr, up by 24%, as compared to Rs109cr for June quarter of FY21.
The company’s results by reporting segment showed Income from operations for the Basic Chemistry Products at Rs1,839cr, up by 10%, and Specialty Products at Rs766cr, up by 13%, as compared to June quarter of FY21.
“With the country gradually reopening, we are witnessing the revival of the chemical sector and customer demand. Our plant operations and capacity utilisation have gained momentum and are getting back to the pre-Covid levels. While we are scaling up our operations and ensuring business continuity, the health and safety of our employees and customers will remain our priority.
In the coming quarters, we are aiming to move up the value chain with our business strategy concentrating on four verticals - performance materials, nutritional sciences, agro sciences and energy sciences, while maintaining cash flow and cash balances,” R. Mukundan, Managing Director & CEO, Tata Chemicals Ltd., said.